The Future of Cancer Immunotherapy: Biomarkers, Tumor Microenvironment, and Precision Medicine
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 3266
Special Issue Editor
Interests: cancer research; immunity; microbiome; immunology; chromatin biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is a complex and diverse disease influenced by genetic, environmental, and lifestyle factors. Despite significant progress in medical science, it remains one of the leading causes of death worldwide, affecting millions of people every year. Standard treatments for various cancer types, which include surgery, radiotherapy, and chemotherapy, have shown limited success. This highlights the urgent need for the development of new therapies. Recently, there has been a growing emphasis on immunotherapy and personalized medicine as promising strategies for more effectively combating cancer. Current immune checkpoint inhibitors and CAR T-cell therapies face challenges, especially in the treatment of solid tumors. This underscores the necessity for additional clinical biomarkers to identify new therapeutic targets within the realm of personalized medicine. With the advent of high-throughput techniques, both genomics and proteomics have become crucial for identifying mutations that drive tumor initiation and progression, as well as for discovering relevant biomarkers for chemotherapy and immunotherapy. Additionally, proteomic profiling of hematological malignancies and solid tumors will provide deeper insights into the intrinsic and extrinsic factors that shape the tumor microenvironment. This knowledge will facilitate the customization of personalized medicine for various cancer types. By leveraging our current understanding of immunotherapy and conducting genomic and proteomic analyses of cancer patient samples, we can uncover new targets that can aid in the development of novel therapies. Ultimately, this approach aims to enhance life expectancy for cancer patients.
Dr. Aftab Alam
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunotherapy
- genomics
- proteomics checkpoint
- CAR T cells
- predictive biomarkers
- resistance mechanisms
- combination approaches
- tumor microenvironment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
